pyrazolopyridine and Neurodegenerative-Diseases

pyrazolopyridine has been researched along with Neurodegenerative-Diseases* in 2 studies

Other Studies

2 other study(ies) available for pyrazolopyridine and Neurodegenerative-Diseases

ArticleYear
Synthesis of new heterocyclic compounds based on pyrazolopyridine scaffold and evaluation of their neuroprotective potential in MPP
    European journal of medicinal chemistry, 2017, Mar-31, Volume: 129

    Neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, and Huntington's disease affect millions of people in the world. Thus several new approaches to treat brain disorders are under development. The aim of the present study is to synthesize potential neuroprotective heterocyclic compounds based on pyrazolopyridine derivatives and then to evaluate their effects in MPP

    Topics: Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Heterocyclic Compounds; Humans; Neuroblastoma; Neurodegenerative Diseases; Neuroprotective Agents; Pyrazoles; Pyridines

2017
Synthesis of 2- and 2,3-substituted pyrazolo[1,5-a]pyridines: scope and mechanistic considerations of a domino direct alkynylation and cyclization of N-iminopyridinium ylides using alkenyl bromides, alkenyl iodides, and alkynes.
    The Journal of organic chemistry, 2011, Oct-21, Volume: 76, Issue:20

    Direct functionalization and tandem processes have both received considerable recent interest due to their cost and time efficiency. Herein we report the synthesis of difficult to obtain 2-substituted pyrazolo[1,5-a]pyridines through a tandem palladium-catalyzed/silver-mediated elimination/direct functionalization/cyclization reaction involving N-benzoyliminopyridinium ylides. As such, these biologically important molecules are prepared in an efficient, high-yielding manner, only requiring a two-step sequence from pyridine. Aryl-substituted alkenyl bromides and iodides are effective ylide coupling partners. Mechanistic studies led to the use of terminal alkynes, which extended the scope of the reaction to include alkyl substitution on the unsaturated reactive site. The optimization, scope, and mechanistic considerations of the process are discussed.

    Topics: Alkenes; Alkynes; Bromides; Catalysis; Chemistry, Pharmaceutical; Cyclization; Dopamine Agonists; Dopamine Antagonists; Humans; Iodides; Magnetic Resonance Spectroscopy; Neurodegenerative Diseases; Palladium; Pyrazoles; Pyridines; Receptors, Dopamine; Silver

2011